ISRCTN49127736
Completed
未知
European Randomised study of Screening for Prostate Cancer
Erasmus Medical Centre (Netherlands)0 sites251,133 target enrollmentDecember 20, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Erasmus Medical Centre (Netherlands)
- Enrollment
- 251133
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males aged 55 \- 74 years (including age 74\)
Exclusion Criteria
- •Previous diagnosis of prostate cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
European Randomized Study of Screening for Prostate Cancer.NL-OMON29632Prof. dr. F.H. SchröderDept. UrologyErasmus MCP.O. Box 20403000 CA RotterdamThe Netherlandstel. +31-10-463 43 28fax. +31-10-463 39 68E-mail: e.vandenberg@erasmusmc.nl251,133
Recruiting
Phase 3
Treatment for Benign Prostatic Hyperplasia, a comparative study between dual pharmacological treatment (Tamsulosin and Finasteride) and a minimally invasive Prostatic Urethral Lift procedure (Urolift)Prostate HyperplasiaRBR-1094jttzniversidade de São Paulo
Recruiting
Not Applicable
Prostate Cancer Screening with short, unenhanced Magnetic Resonance ImagingbpMRI of the prostateDRKS00031035Charité Universitätsmedizin Berlin, Klinik für Radiologie900
Active, not recruiting
Not Applicable
Partial prostate Ablation versus Radical Treatment (PART): Comparing partial ablation of the prostate to treatment or removal of the whole prostate in men with localised cancer of one side of the prostate onlyProstate cancerCancerISRCTN17249875niversity of Oxford800
Active, not recruiting
Not Applicable
A Clinical Phase II Study in Patients with Prostate Cancer and Bone Metastases with KML001 (KOMINOX®) - KML001 in patients with prostate cancer and bone metastasesProstate Cancer MetastaticMedDRA version: 8.1Level: LLTClassification code 10036909Term: Prostate cancer metastaticEUCTR2006-005607-33-DEKOMINOX USA, Inc.